insights_auto
Bakit bumaba ang EVGN 2.46%?
Tingnan ang Higit pang Detalyechevron_right
EVGN:NASDAQ
Evogene Ltd
$0.38
arrow_downward
-2.46%(-0.0096) 1D
Okt 14, 10:21:48 AM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa EVGN...
Buksan
$0.38
Mataas
$0.39
Mababa
$0.37
Mkt. cap
6.87M
Avg. na dami
2.57M
Dami
7.54K
Mataas nang 52-wk
$1.49
Mababa nang 52-wk
$0.35
EPS
-$0.90
Beta
1.44
Mga natitirang share
18.05M
Bilang ng mga empleyado
52
Buksan
$0.38
Mataas
$0.39
Mababa
$0.37
Mkt. cap
6.87M
Avg. na dami
2.57M
Dami
7.54K
Mataas nang 52-wk
$1.49
Mababa nang 52-wk
$0.35
EPS
-$0.90
Beta
1.44
Mga natitirang share
18.05M
Bilang ng mga empleyado
52
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
10 oras ang nakalipas
Evogene reaches board deal: what it means for Evogene stock
Profile
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Tungkol sa Evogene Ltd